Mithril Medicine advanced an antibody treatment candidate for muscular dystrophy from initial concept to proof of principle in mice within 18 months

Drug pricing and affordability, FDA drug approvals, clinical trial design, drug shortages, insurer coverage, pharmaceutical regulation, and medication access.

General research and information gathering from multiple sources